The pharmaceutical company AstraZeneca announced today that the her vaccine against Covid-19Vaxzevria, approved by the European Union regulator (Coreper) as third booster dose.
Now, the vaccine can be used as souvenirafter vaccination with two doses of Vaxzevria or by people who have previously been vaccinated with an mRNA vaccine, such as the Pfizer / BioNTech and Moderna vaccines.
«Ensuring longer-lasting immunoprotection is key to the long-term management of Covid-19 as a whole, and booster doses can counteract the weakening of protection over time that has been identified with all basic vaccination regimens to date.“, States in an announcement o I live in PangalosExecutive Vice President of Biopharmaceutical Research and Development at AstraZeneca.
The European Medicines Agency has approved the use of Vaxzevria as a booster dose a few weeks after the European regulator approved the use of Pfizer-BioNTech Comirnaty vaccine as a booster dose for adults who have completed the basic vaccine with other vaccines. .
Vaccine pharmaceutical companies have made it known that The largest volume of vaccinations this year will be booster doses or the basic vaccination regimen for children as it receives worldwide approval.
The decision of the European regulatory authority must be formally ratified by the European Commission.
Follow Skai.gr on Google News
and be the first to know all the news
